Related Experiment Videos
[Cluster headache--clinical aspects, pathophysiology and treatment]
1Nevrologisk avdeling, Nordland Sentralsykehus, 8092 Bodø. rolf.salvesen@c2i.net
Summary
Cluster headache, a severe neurological disorder, affects less than 1% of people, predominantly men. Effective treatments include sumatriptan injections, oxygen, and prophylactic medications like verapamil.
Area of Science:
- Neurology
- Neuroscience
Background:
- Cluster headache affects less than 0.1% of the general population, with a higher prevalence in men.
- Characterized by severe, unilateral orbital, supraorbital, or temporal pain.
- Attacks are accompanied by autonomic symptoms such as conjunctival injection, lacrimation, nasal congestion, and sometimes Horner's syndrome.
Purpose of the Study:
- To review the clinical features, pathophysiology, and treatment of cluster headache.
- To highlight the role of the hypothalamus in cluster headache pathophysiology.
- To summarize current acute and prophylactic treatment strategies.
Main Methods:
- Review of epidemiological data.
- Description of clinical presentation and diagnostic criteria.
- Summary of current understanding of pathophysiology.
- Overview of established treatment options.
Main Results:
- Cluster headache is a distinct syndrome with characteristic unilateral pain and autonomic features.
- Attacks are episodic, occurring multiple times daily for weeks to months, followed by remissions.
- The hypothalamus is implicated in the pathophysiology of cluster headache.
- Sumatriptan injection and oxygen inhalation are effective acute treatments.
- Verapamil, lithium, and steroids are commonly used prophylactic agents.
Conclusions:
- Cluster headache is a debilitating condition requiring specific management strategies.
- Understanding the hypothalamic involvement may lead to novel therapeutic approaches.
- A combination of acute and prophylactic treatments is often necessary for effective patient management.